|
 |
| INTERESTING IMAGE |
|
|
|
| Year : 2020 | Volume
: 35
| Issue : 4 | Page : 342-344 |
|
|
Muscle infiltrative adult multisystem langerhans cell histiocytosis detected on fluorodeoxyglucose positron emission tomography/computed tomography – A rare case
Sampanna Jung Rayamajhi1, Rajive Raj Shahi1, Sagar Maharjan1, Samir Sharma2, KC Sudhir Suman1
1 Kundalini Diagnostic Center, Kathmandu, Nepal
2 Narayani Samudaik Hospital and Research Center, Bharatpur, Chitwan, Nepal
| Date of Submission | 03-May-2020 |
| Date of Decision | 18-May-2020 |
| Date of Acceptance | 23-May-2020 |
| Date of Web Publication | 21-Oct-2020 |
Correspondence Address:
Dr. Sampanna Jung Rayamajhi
Kundalini Diagnostic Center, Banshidhar Marg, 44600, Kathmandu
Nepal
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijnm.IJNM_88_20
 Abstract | | |
Langerhans cell histiocytosis (LCH) is a disease of unknown pathogenesis characterized by the accumulation of Langerhans cells which show immunopositivity for S-100 and CD1a. LCH with skeletal muscle involvement has been rarely described in literature. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is an important tool in identifying the sites of involvement in LCH. We present a rare case of muscle invasive LCH where 18F-FDG PET/CT showed involvement of multiple other sites such as the liver, bones, bone marrow, and possibly the thyroid gland in our case. Further, the current case also shows that liver involvement by LCH (possibly fibrotic phase) can be negative on PET but show lesions on CT.
Keywords: Fluorodeoxyglucose, Langerhans cell histiocytosis, positron emission tomography
How to cite this article:
Rayamajhi SJ, Shahi RR, Maharjan S, Sharma S, Sudhir Suman K C. Muscle infiltrative adult multisystem langerhans cell histiocytosis detected on fluorodeoxyglucose positron emission tomography/computed tomography – A rare case. Indian J Nucl Med 2020;35:342-4 |
How to cite this URL:
Rayamajhi SJ, Shahi RR, Maharjan S, Sharma S, Sudhir Suman K C. Muscle infiltrative adult multisystem langerhans cell histiocytosis detected on fluorodeoxyglucose positron emission tomography/computed tomography – A rare case. Indian J Nucl Med [serial online] 2020 [cited 2021 Feb 26];35:342-4. Available from: https://www.ijnm.in/text.asp?2020/35/4/342/298757 |
Langerhans cell histiocytosis (LCH) is a disease of unknown pathogenesis characterized by the accumulation of Langerhans cells which show immunopositivity for S-100 and CD1a. The disease spectrum ranges from solitary organ involvement to multisystem disease. The incidence is higher in children as compared to adults.
Skeletal muscle involvement is extremely rare, and only few cases have been described in literature.[1],[2],[3] Liver involvement is also considered rare in adults, a finding seen in extensive LCH and indicates bad prognosis.[4] We report a rare case of multisystemic adult LCH, presenting with multiple skeletal muscle lesions along with liver, bone, diffuse bone marrow, and possibly thyroid involvement.
18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is an established tool in identifying the extent of disease involvement in LCH, which could potentially change management.[5],[6] Our patient was a 41-year-old female who initially presented with progressive discomfort of the right neck and shoulder region. Biopsy and immunohistochemistry of the right neck mass revealed immunopositivity for S-100 and CD1a. Subsequently, she underwent PET/CT from the vertex to the mid-thigh with intravenous contrast.
There was extensive FDG-avid mass-like diffuse enlargement of the right subscapularis muscle along with focally FDG-avid areas involving the right anterior and middle scalene, infraspinatus, trapezius, and right intercostal muscles [
[Figure 1]a, [Figure 1]b, [Figure 1]c, [Figure 1]d, [Figure 1]e. Some of the FDG-avid foci in the muscles involved did not have changes on CT. | Figure 1: Maximum-intensity projection image (a), demonstrating fluorodeoxyglucose-avid lesions in the muscles, bones, thyroid gland, and diffusely increased fluorodeoxyglucose uptake in the bone marrow. Axial computed tomography (b) showing mass-like enlargement of the right subscapularis muscle and fused positron emission tomography/computed tomography (c) showing fluorodeoxyglucose-avid lesions in the right subscapularis muscle along with lytic changes in the scapula. Axial computed tomography (d) showing mass – slightly bulky right infraspinatus muscle and fused positron emission tomography/computed tomography (e) showing fluorodeoxyglucose-avid lesions in the right infraspinatus muscle
Click here to view |
There was lytic destruction of the right scapula [Figure 1]d and [Figure 1]e and FDG-avid lytic lesions in the left femoral head and left scapula [Figure 2]. | Figure 2: Axial computed tomography (a) and fused positron emission tomography/computed tomography (b) showing fluorodeoxyglucose-avid lytic lesion in the left femoral head and axial computed tomography (c) and fused positron emission tomography/computed tomography (d) showing lytic lesion in the left scapula
Click here to view |
Diffuse confluent nonenhancing hypodense lesions were seen in both the lobes of the liver, which were normal in size with some of the lesions appearing as band along the portal tracts [Figure 3], compatible with hepatic involvement of LCH.[4] Bilirubin, alanine transaminase, and aspartate transaminase were normal. Alkaline phosphatase was significantly elevated reaching 1492 (normal: 20–140 IU/L), representing severe cholestasis. Liver involvement in LCH is considered to progress through the following four histopathological stages: proliferative, granulomatous, xanthomatous, and fibrous phases.[7] The liver lesions in our case did not reveal high FDG uptake, which may possibly reflect advanced fibrotic phase [Figure 3]b and [Figure 3]d. | Figure 3: Axial computed tomography (a) showing avid confluent hypodense lesions without corresponding increased fluorodeoxyglucose uptake in the fused positron emission tomography/computed tomography (b). Coronal computed tomography (c) and fused positron emission tomography/computed tomography (d) showing these hypodense lesions along the portal tract
Click here to view |
The entire bone marrow showed diffusely increased FDG uptake, reflecting bone marrow involvement [Figure 1]a, maximum-intensity projection image]. There was diffusely increased FDG uptake in the enlarged thyroid gland [Figure 1]a with ill-defined hypodense nodules, possibly be due to LCH involvement which is considered rare.[8],[9] Interestingly, the lungs revealed no nodular or cystic changes. In addition, other known manifestations of LCH such as cutaneous lesions and CNS lesions were not seen.
In conclusion, we describe a rare case of adult LCH involving the skeletal muscles, some of them without changes on CT but seen on fused PET/CT images. Second, the current case also shows that liver involvement by LCH (possibly fibrotic phase) can be negative on PET but show lesions on CT.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Shao D, Wang S. Diffuse subcutaneous and muscular Langerhans cell histiocytosis on FDG PET/CT. Clin Nucl Med 2019;44:589-90.  |
| 2. | Narayan D, Figueira E, Kearney D, McKelvie P, Davis G, Selva D. Unifocal Langerhans cell histiocytosis of the superior oblique muscle. Ophthalmic Plast Reconstr Surg 2015;31:e60-1. |
| 3. | May DA, Kaushik S, Frable WJ. MR imaging of infiltrative muscle involvement with Langerhans cell histiocytosis. Clin Imaging 2004;28:301-4. |
| 4. | Abdallah M, Généreau T, Donadieu J, Emile JF, Chazouillères O, Gaujoux-Viala C, et al. Langerhans' cell histiocytosis of the liver in adults. Clin Res Hepatol Gastroenterol 2011;35:475-81. |
| 5. | Agarwal KK, Seth R, Behra A, Jana M, Kumar R. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: Spectrum of manifestations. Jpn J Radiol 2016;34:267-76. |
| 6. | Albano D, Bosio G, Giubbini R, Bertagna F. Role of (18)F-FDG PET/CT in patients affected by Langerhans cell histiocytosis. Jpn J Radiol 2017;35:574-83. |
| 7. | Shi Y, Qiao Z, Xia C, Gong Y, Yang H, Li G, et al. Hepatic involvement of Langerhans cell histiocytosis in children--imaging findings of computed tomography, magnetic resonance imaging and magnetic resonance cholangiopancreatography. Pediatr Radiol 2014;44:713-8. |
| 8. | Saqi A, Kuker AP, Ebner SA, Ausiello J, Jobanputra V, Bhagat G, et al. Langerhans cell histiocytosis: Diagnosis on thyroid aspirate and review of the literature. Head Neck Pathol 2015;9:496-502. |
| 9. | Long Q, Shaoyan W, Hui W. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary thyroid Langerhans histiocytosis: A case report and literature review. Indian J Nucl Med 2015;30:328-30. [ PUBMED] [Full text] |
[Figure 1], [Figure 2], [Figure 3]
|
